1Olah KS,Dunn JA,Gee H.Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumors when adjusting for known prognostic factors:the result of a retrospective study of 423 cases of uterine sarcoma.BrJ Obstet Gynecol,2002,109(4):590
2Pautier P,Genestic C.Rre A,et al. Analysis of clinicopathologic prognostic factors for 157 uterine sarcoma and evalutation of grading score validated for soft tissue sareoma[J]. Cancer,2000, 88:1425-1431.
3Alvarado Gay FJ, Vega Silva E. Uterine leiomyosarcoma. A report of a case. Ginecol Obstet Mex[J]. 2005,73(1):54- 58.
4Kawamura N, Ichimura T, Ito F, et al. Transcervical needle biopsy for the differential diagnosis between uterine sarcoma and leiomyoma[J]. Cancer, 2002.94(6) :1713-1720.
5Nappi L. Di Spiezio Sardo A, Indraccolo U, et al. Hysteroscop ic resection of uterine leiomyosarcoma: a case report and literature review[J].J Minim Invasive Gynecol, 2008,15(3):380- 383.
6Ronald EH, Steven P, Trudy RB. Impact on progression-free survival of adjuvant cyclophosphamide, vincristine, doxorubicin (adriamycin). and dacarbazine CYvADIC chemotherapy for stage I uterine sarcoma[J].Am J Clin Oncol,1995,18:282 -286.
7Landreat V, Paillocher N, Calala L, et al. Low-grade endometrial stromal sarcoma of the uterus:review of 10 cases[J]. An ticancer Res, 2008,28(5B):2869- 2874.
8Abeler VM. Ryne O, Thoresen S, et al. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients[J]. Histopathology,2009,54(3) :355- 364.
9Ghaemmaghami F, Karimi Zarchi M, Gilani MM, et al. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran[J]. Asian Pac J Cancer Prey. , 2008,9(3) :421-426.
